Related Experiment Video
Updated: Jun 8, 2025
10:39
Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
13.1K
Breast cancer cells utilize T3 to trigger proliferation through cellular Ca2+ modulation
Ines Tawfik1, Katharina Schlick2, Julian Ostaku1
1Division of Molecular Biology and Biochemistry, Medical University of Graz, Neue Stiftingtalstraße 6/IV, Graz, 8010, Austria.
Cell Communication and Signaling : CCS
|November 7, 2024
Summary
Thyroid hormone triiodothyronine (T3) boosts breast cancer cell proliferation by increasing mitochondrial calcium uptake and ATP production. This T3-driven pathway supports cancer viability but not that of normal cells, offering a potential therapeutic target.
Area of Science:
- Endocrinology
- Cancer Biology
- Cell Metabolism
Background:
- Elevated thyroid hormone levels correlate with increased breast cancer risk and progression.
- Triiodothyronine (T3) enhances mitochondrial ATP production in cancer cells by upregulating calcium handling proteins.
Purpose of the Study:
- To investigate if T3 activates a calcium-induced signaling pathway promoting breast cancer cell proliferation.
- To explore the differential effects of T3 on various cancer and non-cancerous cell types.
Main Methods:
- Live-cell imaging
- Biochemical assays
- Molecular profiling
- Comparative analysis across MCF7, MDA-MB-468, hTERT-HME1, and PC3 cell lines.
Main Results:
- T3 upregulates the 1,4,5-trisphosphate receptor 3 via thyroid hormone receptor α.
- This leads to increased mitochondrial calcium uptake and ATP production, enhancing breast cancer cell viability and proliferation.
- T3 did not affect the proliferation of non-cancerous breast cells (hTERT-HME1) or prostate cancer cells (PC3).
Conclusions:
- T3 acts as a key regulator of breast cancer cell metabolism and proliferation through a specific calcium-signaling pathway.
- Targeting the T3 pathway could offer novel therapeutic strategies for breast cancer by exploiting cancer cell-specific vulnerabilities.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
01:16Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
02:18Cancer
48.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.1K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K